LCG
DXCM icon

Lisanti Capital Growth’s DexCom DXCM Stock Holding History

Lisanti Capital Growth’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22,144
Closed -$1.49M – 125
2020
Q1 		$1.49M Sell
22,144
-448
-2% -$27.9K 0.49% 75
2019
Q4 		$1.24M Buy
+22,592
New +$1.07M 0.33% 88
2019
Q1 		– Sell
-67,020
Closed -$2.01M – 116
2018
Q4 		$2.01M Buy
67,020
+6,940
+12% +$220K 0.81% 53
2018
Q3 		$2.15M Sell
60,080
-7,660
-11% -$237K 0.75% 62
2018
Q2 		$1.61M Buy
67,740
+20,620
+44% +$437K 0.62% 70
2018
Q1 		$874K Buy
+47,120
New +$697K 0.42% 93
2015
Q3 		– Sell
-88,720
Closed -$1.77M – 88
2015
Q2 		$1.77M Sell
88,720
-31,364
-26% -$551K 1.28% 41
2015
Q1 		$1.87M Sell
120,084
-119,240
-50% -$1.8M 1.07% 45
2014
Q4 		$3.29M Sell
239,324
-27,604
-10% -$338K 1.65% 15
2014
Q3 		$2.67M Buy
266,928
+106,020
+66% +$1.08M 1.34% 28
2014
Q2 		$1.59M Sell
160,908
-147,680
-48% -$1.31M 0.71% 69
2014
Q1 		$3.19M Sell
308,588
-238,492
-44% -$2.47M 1.38% 27
2013
Q4 		$4.84M Buy
547,080
+192,760
+54% +$1.53M 2.04% 3
2013
Q3 		$2.5M Sell
354,320
-244,800
-41% -$1.55M 1.14% 33
2013
Q2 		$3.26M Buy
+599,120
New +$2.87M 1.56% 17

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Lisanti Capital Growth's DXCM Position: Q2 2020 in Review

Lisanti Capital Growth sold out of DexCom (DXCM) in Q2 2020, closing a stake of 22,144 shares — an estimated $1.49M sold.

Lisanti Capital Growth first reported a position in DXCM in Q2 2013 and held it in 15 quarters. The position peaked at $4.84M in Q4 2013. 723 funds tracked by Wall St. Rank hold DXCM as of Q2 2020.

  • Lisanti Capital Growth reported no remaining DexCom position as of Q2 2020 after selling out during the quarter.
  • Lisanti Capital Growth sold 22,144 DexCom shares in Q2 2020, an estimated $1.49M.
  • Lisanti Capital Growth first reported a position in DexCom in Q2 2013 and held it in 15 quarters.
  • Lisanti Capital Growth's DexCom position peaked at $4.84M in Q4 2013.
  • 723 funds tracked by Wall St. Rank held DexCom as of Q2 2020.

Based on Lisanti Capital Growth's 13F filing for Q2 2020, filed 10 Aug 2020.